Abstracts: [Administration of micronized palmitoylethanolamide (PEA)-transpolydatin in the treatment of chronic pelvic pain in women affected by endometriosis: preliminary results]. [Article in Italian] Lo Monte G1, Soave I, Marci R. Author information Abstract AIM: Aim of the study was to evaluate the effectiveness of micronized palmitoylethanolamide (PEA)-transpolydatin in the treatment of chronic pelvic pain in women affected by …
Month: December 2018
Studies/Abstracts: Palmitoylethanolamide and Osteoarthritis “Palmitoylethanolamide shows benefit in knee osteoarthritis Steels E & al. Inflammopharmacology 29 Mar 2019 Palmitoylethanolamide (PEA) improved function and reduced pain, stiffness, and anxiety without serious toxicity in a randomized controlled trial (RCT) of patients with knee osteoarthritis (KOA). Why this matters PEA has the potential to be a natural, nontoxic, and …
Studies on the use of Palmitoylethanolamide (PEA) for Carpal Tunnel This study suggests doses higher than 600mg per day are necessary. Use of palmitoylethanolamide in carpal tunnel syndrome: a prospective randomized study. J Orthop Traumatol. 2017 Dec; 18(4): 451–455. Jordi Faig-Martí, Adriana Martínez-Catassús Published online 2017 Mar 15. doi: 10.1007/s10195-017-0453-z The results of this study suggest that treatment of …
Research on Palmitoylethanolamide (PEA) & Neuropathy J Pain Res. 2012; 5: 437–442. Published online 2012 Oct 26. doi: 10.2147/JPR.S32143 PMCID: PMC3500919 PMID: 23166447 Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series Jan M Keppel Hesselink and Thecla AM Hekker ” Abstract Palmitoylethanolamide (PEA), an endogenous fatty acid amide, has been demonstrated to …
Studies Related to Palmitoylethanolamide and Dental Pain ” Br J Clin Pharmacol. 2016 Oct; 82(4): 932–942. Published online 2016 Jun 29. doi: 10.1111/bcp.13020 PMCID: PMC5094513 PMID: 27220803 Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy Linda Gabrielsson, 1 Sofia Mattsson, 1 and Christopher J. Fowler 1 Abstract Palmitoylethanolamide (PEA) has been suggested to have useful analgesic properties and to be devoid of unwanted …
Palmitolyethanolamide (PEA) Shown To Be Effective In Reducing Influenza & Common Cold It is not well known that over the past 25 years, PEA (Palmitoylethanolamide) has been tested as a therapy for both influenza and the common cold. In fact, as early as 1939, food supplements (dried egg yolks fed to poor children in …
Palmitoylethanolamide Infection – Influenza and Common ColdRead More »
Research Article in Frontiers in Pharmacology Shows That PEA Supplementation Reduces Airway Sensitivity Symptoms in Mice You can create asthma symptoms in mice by a process called “allergen sensitization”. This is related to the role of mast cells in asthma. PEA appears to be a “down-regulator” of mast cell activity in the airways. The first …
Recent Comments